Our research employs multidisciplinary methods which include pharmacology, neuroscience, and immunology projects. In collaboration with industry partners we also utilise cutting-edge Artificial Intelligence (AI) based approaches to enable us to identify new drugs and therapeutic targets.

Below is a summary of our research projects:

  • Validation of novel therapeutic targets for neuroinflammation and neurodegeneration
  • Repurposing of drugs for progressive neurodegenerative diseases
  • Discovery and validation of clinical biomarkers for neurodegenerative diseases
  • Neuroinflammatory mechanisms that drive disease progression
  • Application of Artificial Intelligence (AI) technologies for therapeutic development

We are always keen to recruit curious, passionate and enthusiastic students, researchers and scientific entrepreneurs to join our team. Please get in touch with Richard to discuss support for PhD, Honours, Masters and international exchange programs. We are also able to provide research support for visiting scholars and research fellows.